The Legal Examiner Affiliate Network The Legal Examiner The Legal Examiner The Legal Examiner search feed instagram google-plus avvo phone envelope checkmark mail-reply spinner error close The Legal Examiner The Legal Examiner The Legal Examiner
Skip to main content
| The Cochran Firm - Dallas

The Food and Drug Administration announced last they are finally looking into Chantix, a stop smoking medication, to find out how dangerous it might be.

Since the report of Carter Albrecht’s unusual behavior and death while taking Chantix, hundreds of other Chantix patients have spoken up about the effects they’ve experienced. Over the last two months, Ryann Rathbone said she has received countless e-mails from people thanking her for bringing attention to the possible side effects of Chantix.

The FDA recieved ofer 5,000 complaints from Chantix patients including over 200 reports of suicide or suicidal thoughts, about 500 cases of depression and many others complained of unusual anger, aggression, amnesia, hallucination and homicidal thoughts as early as two days after starting Chantix to help quit smoking.

The FDA said they are looking into 100 specific psychotic incidents in the United States.

Even before Albrecht’s death, the FDA said they had planned an investigation based on complaints in Europe where Pfizer sold the drug as Champix since 2006.

The FDA is urging doctors to carefully monitor patients on the drug. People should also report side effects to the FDA.

For more information on this subject, please refer to the section on Drugs, Medical Devices and Implants.

Comments are closed.